| SOS | Suppression of Splicing |
| NMD | Nonsense Mediated mRNA Decay |
| Pol II | RNA Polymerase II |
| RNP | Ribonucleoprotein |
| snRNP | small nuclear RNP |
| AS | Alternative Splicing |
| SS | Splice Site |
| hnRNP | heterogenous nuclear Ribonucleoproteins |
| PTCs | Premature Termination Codons |
| NAS | Nonsense-mediated Altered Splicing |
| ORF | Open Reading Frame |
| LSS | Latent 5′ Splice Site |
| Ini-tRNA | initiator-tRNA |
| NCL | Nucleolin |
| CAD31 | CAD-Mut31 |
| GEO | Gene Expression Omnibus |
| TBR1 | T box brain 1 |
| SV2B | Synaptic Vesicle glycoprotein 2B |
| OD | Oligodendroglioma |
| ODII | Oligodendroglioma Grade II |
| ODIII | Oligodendroglioma Grade III |
| BC | Breast Cancer |
| GC | Glioma Cancer |
| EPB49 | Erythrocyte membrane protein band 4.9 (Dematin) |
| LPCAT4 | Lysophosphatidylcholine acyltransferase 4 |
| MET | Met proto-oncogene (hepatocyte growth factor receptor) |
| PRKAA2 | Protein kinase, AMP-activated, alpha 2 catalytic subunit |
| VHP | Villin Headpiece |
| PlsC | Phosphate acyltransferases |
| Sema | Semaphorin domain |
| PSI | Plexins, Semaphorins and Integrins |
| IPT | Ig-like, plexins, transcription factors |
| TyrKc | Tyrosine kinase |
| S_TKc | Serine/Threonine protein kinases |
| BRCA | Breast invasive carcinoma |
| GBM | Glioblastoma multiforme |
| LGG | Brain Lower Grade Glioma |
| GEPIA | Gene Expression Profiling Interactive Analysis |
| DMTN | Dematin |
| AMPK | AMP-activated protein Kinase |